These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 22147909)
1. Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. Prieto-Alhambra D; Javaid MK; Judge A; Murray D; Carr A; Cooper C; Arden NK BMJ; 2011 Dec; 343():d7222. PubMed ID: 22147909 [TBL] [Abstract][Full Text] [Related]
2. Oral bisphosphonate use and total knee/hip implant survival: validation of results in an external population-based cohort. Prieto-Alhambra D; Lalmohamed A; Abrahamsen B; Arden NK; de Boer A; Vestergaard P; de Vries F Arthritis Rheumatol; 2014 Nov; 66(11):3233-40. PubMed ID: 25047677 [TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study. Prieto-Alhambra D; Javaid MK; Judge A; Maskell J; Cooper C; Arden NK; Ann Rheum Dis; 2015 Mar; 74(3):557-63. PubMed ID: 24451241 [TBL] [Abstract][Full Text] [Related]
4. Postoperative Bisphosphonates Use is Associated with Reduced Adverse Outcomes After Primary Total Joint Arthroplasty of Hip and Knee: A Nationwide Population-Based Cohort Study. Shih JT; Tan TL; Shen PH; Yeh TT; Wu CC; Pan RY; Chien WC; Chung CH; Wang SH Calcif Tissue Int; 2024 May; 114(5):451-460. PubMed ID: 38492035 [TBL] [Abstract][Full Text] [Related]
5. Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry. Khatod M; Inacio MC; Dell RM; Bini SA; Paxton EW; Namba RS Clin Orthop Relat Res; 2015 Nov; 473(11):3412-20. PubMed ID: 25896134 [TBL] [Abstract][Full Text] [Related]
6. The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study. Bayliss LE; Culliford D; Monk AP; Glyn-Jones S; Prieto-Alhambra D; Judge A; Cooper C; Carr AJ; Arden NK; Beard DJ; Price AJ Lancet; 2017 Apr; 389(10077):1424-1430. PubMed ID: 28209371 [TBL] [Abstract][Full Text] [Related]
7. The use of bisphosphonates after joint arthroplasty is associated with lower implant revision rate. Ro DH; Jin H; Park JY; Lee MC; Won S; Han HS Knee Surg Sports Traumatol Arthrosc; 2019 Jul; 27(7):2082-2089. PubMed ID: 30547306 [TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate Use and the Risk of Undergoing Total Knee Arthroplasty in Osteoporotic Patients with Osteoarthritis: A Nationwide Cohort Study in Taiwan. Fu SH; Wang CY; Yang RS; Wu FL; Hsiao FY J Bone Joint Surg Am; 2017 Jun; 99(11):938-946. PubMed ID: 28590379 [TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis. Prieto-Alhambra D; Javaid MK; Judge A; Maskell J; Kiran A; Cooper C; Arden NK Osteoporos Int; 2011 May; 22(5):1555-71. PubMed ID: 20694456 [TBL] [Abstract][Full Text] [Related]
10. Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use. Prieto-Alhambra D; Javaid MK; Judge A; Maskell J; Kiran A; de Vries F; Cooper C; Arden NK Arthritis Rheum; 2011 Apr; 63(4):992-1001. PubMed ID: 21452321 [TBL] [Abstract][Full Text] [Related]
11. Comorbid diseases as predictors of survival of primary total hip and knee replacements: a nationwide register-based study of 96 754 operations on patients with primary osteoarthritis. Jämsen E; Peltola M; Eskelinen A; Lehto MU Ann Rheum Dis; 2013 Dec; 72(12):1975-82. PubMed ID: 23253916 [TBL] [Abstract][Full Text] [Related]
12. Multi-state models and arthroplasty histories after unilateral total hip arthroplasties: introducing the Summary Notation for Arthroplasty Histories. Gillam MH; Ryan P; Salter A; Graves SE Acta Orthop; 2012 Jun; 83(3):220-6. PubMed ID: 22553904 [TBL] [Abstract][Full Text] [Related]
13. Outcomes After Metal-on-metal Hip Revision Surgery Depend on the Reason for Failure: A Propensity Score-matched Study. Matharu GS; Judge A; Murray DW; Pandit HG Clin Orthop Relat Res; 2018 Feb; 476(2):245-258. PubMed ID: 29529653 [TBL] [Abstract][Full Text] [Related]
14. Mortality and implant revision rates of hip arthroplasty in patients with osteoarthritis: registry based cohort study. McMinn DJ; Snell KI; Daniel J; Treacy RB; Pynsent PB; Riley RD BMJ; 2012 Jun; 344():e3319. PubMed ID: 22700782 [TBL] [Abstract][Full Text] [Related]
15. Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared with osteoarthritis: a prospective, population-based study on 108,786 hip and knee joint arthroplasties from the Norwegian Arthroplasty Register. Schrama JC; Espehaug B; Hallan G; Engesaeter LB; Furnes O; Havelin LI; Fevang BT Arthritis Care Res (Hoboken); 2010 Apr; 62(4):473-9. PubMed ID: 20391501 [TBL] [Abstract][Full Text] [Related]
16. Effect of bisphosphonates on knee replacement surgery. Neogi T; Li S; Peloquin C; Misra D; Zhang Y Ann Rheum Dis; 2018 Jan; 77(1):92-97. PubMed ID: 28988204 [TBL] [Abstract][Full Text] [Related]
17. Revision total hip arthoplasty: factors associated with re-revision surgery. Khatod M; Cafri G; Inacio MC; Schepps AL; Paxton EW; Bini SA J Bone Joint Surg Am; 2015 Mar; 97(5):359-66. PubMed ID: 25740025 [TBL] [Abstract][Full Text] [Related]
18. Exclusion of patients with sequential primary total joint arthroplasties from arthroplasty outcome studies biases outcome estimates: a retrospective cohort study. Ravi B; Croxford R; Hawker G Osteoarthritis Cartilage; 2013 Dec; 21(12):1841-8. PubMed ID: 24012621 [TBL] [Abstract][Full Text] [Related]
19. Association between surgeon grade and implant survival following hip and knee replacement: a systematic review and meta-analysis. Fowler TJ; Aquilina AL; Blom AW; Sayers A; Whitehouse MR BMJ Open; 2021 Nov; 11(11):e047882. PubMed ID: 34758989 [TBL] [Abstract][Full Text] [Related]